Mirum Pharmaceuticals Q3 EPS USD -0.87

MIRM•2026-11-03

Mirum Pharmaceuticals reported Q3 EPS of USD -0.87, product sales of USD 185.721 million and operating expenses of USD 245.467 million. Operating loss was USD 59.746 million and net loss was USD 40.766 million.

1. Q3 results

Mirum Pharmaceuticals reported Q3 EPS of USD -0.87, product sales of USD 185.721 million and operating expenses of USD 245.467 million. The company recorded operating income of USD -59.746 million and net income of USD -40.766 million.

Mirum Pharmaceuticals Q3 EPS USD -0.87

1. Q3 results

Related News

Rubrik director John Wendell Thompson reports disposal of $1.58 million in common shares

Banco Macro buys back shares for Ps. 446 million

Triple Flag Precious Metals Q3 adjusted net income $53.1 million

XMax expects Q3 net loss of $12.1 million-$13.1 million; sales fall 34% to $6.42 million

Astec Industries grants director William Waltz 1,759 RSUs under equity incentive plan